Endocrine therapy for prostate cancer is based on the use of drugs that diminish androgen
concentration and androgen receptor (AR) signaling inhibitors and is limited by the …

Simple Summary In this review, we will look into the existing methods to study treatment
resistance to androgen receptor targeted therapies in prostate cancer. This will encompass …

Increasing evidence supports that microRNA (miRNA) plays a significant functional role in
cancer progression by directly regulating respective targets. In this study, the expression …

Abstract Steroid receptor coactivator-1 (SRC-1, also known as NCOA1) frequently functions
as a transcriptional coactivator by directly binding to transcription factors and recruiting to the …

A previous study using miRNA sequencing revealed that exposure to a mixture of phthalates
during pregnancy and lactation dysregulated rno‐miR‐184 and rno‐miR‐141‐3p in the …

Docetaxel resistance is one of the major obstacles that undermine the treatment outcome of
PCa. Exploring molecular mechanisms associated with docetaxel resistance could provide …

Abstract Nuclear receptor coactivator 1 (NCOA1) plays crucial roles in the regulation of gene
expression mediated by a wide spectrum of steroid receptors such as androgen receptor …

The regulation of initiation and progression during carcinogenesis of bladder carcinoma is
not completely elucidated. Dysregulation of microRNAs has been detected to play critical …

Prostate cancer (CaP) is the second leading cause of cancer-related deaths in western men.
Because androgens drive CaP by activating the androgen receptor (AR), blocking AR's …

A considerable number of deposited variants has provided new possibilities for knowledge
discovery in different types of prostate cancer. Here, we analyzed variants located on 3 …